Revenue: As of FY2025 Q3, the actual value is USD 0.

EPS: As of FY2025 Q3, the actual value is USD 0.08.

EBIT: As of FY2025 Q3, the actual value is USD -3.526 M.

Segment Revenue

• Investment Income from Trust Account: $3,343,285 for the three months ended September 30, 2025, and $5,427,225 for the nine months ended September 30, 2025.

Operational Metrics

• General and Administrative Expenses: $179,492 for the three months ended September 30, 2025, and $426,577 for the nine months ended September 30, 2025.
• Net Income: $3,167,377 for the three months ended September 30, 2025, and $5,010,826 for the nine months ended September 30, 2025.

Cash Flow

• Net Cash Used in Operating Activities: - $1,268,544 for the nine months ended September 30, 2025.
• Net Cash Used in Investing Activities: - $300,150,000 for the nine months ended September 30, 2025.
• Net Cash Provided by Financing Activities: $301,709,510 for the nine months ended September 30, 2025.

Unique Metrics

• Cash Balance: $325,010 as of September 30, 2025.
• Investments Held in Trust Account: $305,577,225 as of September 30, 2025.

Future Outlook and Strategy

• Core Business Focus: The company is strategically positioned to capitalize on transformative opportunities, focusing on sectors pivotal to advancing sustainability and innovation, with a keen interest in new energy businesses, circular economy initiatives, and innovative agricultural and food technologies.
• Non-Core Business: The company has entered into a non-binding letter of intent with OnMed LLC for a potential business combination, with further details to be announced upon execution of a definitive agreement.